{"id":3923,"date":"2021-09-23T12:24:38","date_gmt":"2021-09-23T10:24:38","guid":{"rendered":"https:\/\/thoraxzentrum-ruhrgebiet.de\/onkoloji-yayinlari\/"},"modified":"2026-10-21T14:01:42","modified_gmt":"2026-10-21T12:01:42","slug":"onkoloji-yayinlari","status":"publish","type":"page","link":"https:\/\/thoraxzentrum-ruhrgebiet.de\/tr\/onkoloji-yayinlari\/","title":{"rendered":"Onkoloji Yay\u0131nlar\u0131"},"content":{"rendered":"
\n

Behringer, D., ve ark. (2021). \u201c\u00d6nceden Tedavi Planlamas\u0131 \u2013 onkoloji servisinde ileriye d\u00f6n\u00fck bak\u0131m planlamas\u0131n\u0131n uygulanmas\u0131na y\u00f6nelik bir uygulama projesi.\u201d Zeitschrift f\u00fcr Palliativmedizin 22(05): 265-270.<\/p>\n

H\u00fcttmann A, ve ark. Agresif B h\u00fccreli lenfomas\u0131 olan ve alt\u0131 CHOP k\u00fcr\u00fc alan hastalarda rituksimab\u0131n alt\u0131 doza kar\u015f\u0131 sekiz dozu: \u201cAgresif Non-Hodgkin Lenfomalarda Pozitron Emisyon Tomografisi Rehberli Tedavi\u201d (PETAL) \u00e7al\u0131\u015fmas\u0131n\u0131n sonu\u00e7lar\u0131. Ann Hematol. 2019 Jan 4. doi: 10.1007\/s00277-018-3578-0. [Bask\u0131 \u00f6ncesi \u00e7evrimi\u00e7i] PubMed PMID: 30610279.<\/p>\n

Braess J, ve ark. Akut miyeloid l\u00f6semide ard\u0131\u015f\u0131k y\u00fcksek doz sitarabin ve mitoksantron (S-HAM) ile standart \u00e7ift ind\u00fcksiyonun kar\u015f\u0131la\u015ft\u0131r\u0131lmas\u0131: faz 3 \u00e7al\u0131\u015fma. Leukemia. 2018 Dec;32(12):2558-2571. doi: 10.1038\/s41375-018-0268-9. Epub 2018 Oct 1. PubMed PMID: 30275528; PubMed Central PMCID: PMC6286323.<\/p>\n

Kn\u00f6dler M ve ark. Mide kanseri hastalar\u0131nda peritoneal karsinomatoz tedavisi i\u00e7in katumaksomab\u0131n (anti-EpCAM \u00d7 anti-CD3) ara\u015ft\u0131r\u0131ld\u0131\u011f\u0131 randomize faz II \u00e7al\u0131\u015fma. Br J Cancer. 2018 Aug;119(3):296-302. doi: 10.1038\/s41416-018-0150-6. Epub 2018 Jul 10. PubMed PMID: 29988111<\/p>\n

D\u00fchrsen U ve ark. PETAL \u00c7al\u0131\u015fmas\u0131 Ara\u015ft\u0131rmac\u0131lar\u0131.. Agresif Non-Hodgkin Lenfomalarda Pozitron Emisyon Tomografisi Rehberli Tedavi (PETAL): \u00c7ok merkezli, randomize faz III \u00e7al\u0131\u015fma. J Clin Oncol. 2018 Jul 10;36(20):2024-2034. doi: 10.1200\/JCO.2017.76.8093. Epub 2018 May 11. PubMed PMID: 29750632.<\/p>\n

Al-Batran SE, ve ark. Rezektabl mide veya gastro\u00f6zofageal bile\u015fke adenokarsinomu olan hastalarda neoadjuvan dosetaksel, oksaliplatin, florourasil ve l\u00f6kovorin ile epirubisin, sisplatin ve florourasil veya kapesitabin sonras\u0131 histopatolojik regresyon (FLOT4-AIO): \u00e7ok merkezli, a\u00e7\u0131k etiketli, randomize faz 2\/3 \u00e7al\u0131\u015fmas\u0131n\u0131n faz 2 b\u00f6l\u00fcm\u00fcn\u00fcn sonu\u00e7lar\u0131. Lancet Oncol. 2016 Dec;17(12):1697-1708. doi: 10.1016\/S1470-2045(16)30531-9. Epub 2016 Oct 22. PubMed PMID: 27776843.<\/p>\n

Joerger M ve ark. \u0130leri evre k\u00fc\u00e7\u00fck h\u00fccreli d\u0131\u015f\u0131 akci\u011fer kanseri (KHDAK\/NSCLC) hastalar\u0131nda paklitakselin bireyselle\u015ftirilmi\u015f, farmakokinetik (PK) rehberli dozlamas\u0131n\u0131n karboplatin veya sisplatin ile kombinasyonunu de\u011ferlendiren a\u00e7\u0131k etiketli, randomize \u00e7al\u0131\u015fma. Ann Oncol. 2016 Oct;27(10):1895-902. doi: 10.1093\/annonc\/mdw290. Epub 2016 Aug 8. PubMed PMID: 27502710.<\/p>\n

Schuette W, Behringer D, ve ark. CHAMP: KRAS durumuna \u00f6zel vurgu ile, ileri evre primer skuam\u00f6z olmayan k\u00fc\u00e7\u00fck h\u00fccreli d\u0131\u015f\u0131 akci\u011fer kanseri hastalar\u0131n\u0131n tedavisinde panitumumab\u0131n pemetrekset ve sisplatin ile, pemetrekset ve sisplatin ile kar\u015f\u0131la\u015ft\u0131r\u0131ld\u0131\u011f\u0131 faz II \u00e7al\u0131\u015fma. Clin Lung Cancer. 2015 Nov;16(6):447-56. doi: 10.1016\/j.cllc.2015.05.009. Epub 2015 Jun 2. PubMed PMID: 26094080.<\/p>\n

Oza AM, ve ark. Yeni tan\u0131 alm\u0131\u015f over kanserli kad\u0131nlarda standart kemoterapiye bevacizumab eklenmesi veya eklenmemesi (ICON7): faz 3 randomize \u00e7al\u0131\u015fman\u0131n genel sa\u011fkal\u0131m sonu\u00e7lar\u0131. Lancet Oncol. 2015 Aug;16(8):928-36. doi: 10.1016\/S1470-2045(15)00086-8. Epub 2015 Jun 23. PubMed PMID: 26115797; PubMed Central PMCID: PMC4648090.
\n10. Proetel U ve ark. Kronik miyeloid l\u00f6semili (\u226565 ya\u015f) ya\u015fl\u0131 hastalar, gen\u00e7 hastalara k\u0131yasla daha y\u00fcksek imatinib dozlar\u0131ndan daha fazla fayda g\u00f6rmektedir: randomize CML-Study IV \u00e7al\u0131\u015fmas\u0131n\u0131n bir alt analizi. Ann Hematol. 2014 Jul;93(7):1167-76. PubMed PMID: 24658964; PubMed Central PMCID: PMC4050299.<\/p>\n

Dittrich C, ve ark. Lokal ileri veya metastatik skuam\u00f6z olmayan k\u00fc\u00e7\u00fck h\u00fccreli d\u0131\u015f\u0131 akci\u011fer kanserinde ikinci basamak tedavi olarak pemetrekset ile pemetrekset+erlotinibin kar\u015f\u0131la\u015ft\u0131r\u0131ld\u0131\u011f\u0131 randomize faz II \u00e7al\u0131\u015fma. Eur J Cancer. 2014 Jun;50(9):1571-80. doi: 10.1016\/j.ejca.2014.03.007. Epub 2014 Apr 2. PubMed PMID: 24703574.<\/p>\n

Behringer D ve ark. Primer trakea kanserine y\u00f6nelik tedavi yakla\u015f\u0131mlar\u0131. Thorac Surg Clin. 2014 Feb;24(1):73-76. doi: 1016\/j.thorsurg.2013.10.002. PubMed PMID: 24295662.<\/p>\n

Stein A, Kretzschmar A, Behringer D ve ark. Rezeksiyon yap\u0131lamayan metastatik kolorektal kanser hastalar\u0131nda kapesitabin ve bevacizumab: faz II AIO KRK 0105 \u00e7al\u0131\u015fmas\u0131n\u0131n nihai sonu\u00e7lar\u0131. BMC Cancer. 2013 Oct 4;13:454. doi:
\n1186\/1471-2407-13-454. PubMed PMID: 24090011; PubMed Central PMCID: PMC3850951.<\/p>\n

Sand M, ve ark. Akut kolesistiti taklit eden renal h\u00fccreli karsinom kaynakl\u0131 safra kesesi metastaz\u0131. Eur J Med Res. 2009;14:90-2. PubMed PMID: 19258219; PubMed Central PMCID: PMC3351966.<\/p>\n

Gerstner ER, ve ark. MSS (CNS) Hodgkin lenfomas\u0131. Blood. 2008 Sep 1;112(5):1658-61. doi: 10.1182\/blood-2008-04-151563. Epub 2008 Jun 30. PubMed PMID: 18591379; PubMed Central PMCID: PMC3710443.<\/p>\n

Gelos M, Behringer D ve ark. Pankreatik karsinosarkom. Multimodal tedavi olgusu ve literat\u00fcr derlemesi. JOP. 2008 Jan 8;9(1):50-5. Review. PubMed PMID: 18182744.<\/p>\n

Thomas-Kaskel AK ve ark. Retik\u00fcle trombosit say\u0131lar\u0131, idiyopatik trombositopenik purpural\u0131 hastalarda tedavi yan\u0131t\u0131 ile koreledir ve allojenik hematopoietik k\u00f6k h\u00fccre nakli sonras\u0131 hastalarda trombositopeninin karma\u015f\u0131k nedenlerinin belirlenmesine yard\u0131mc\u0131 olur. Cytometry B Clin Cytom. 2007 Jul;72(4):241-8. PubMed PMID: 17266149.<\/p>\n

Heining C, ve ark. Allojenik hematopoietik k\u00f6k h\u00fccre nakli sonras\u0131 lenfosit yeniden yap\u0131lanmas\u0131: 148 hastay\u0131 i\u00e7eren retrospektif \u00e7al\u0131\u015fma. Bone Marrow Transplant. 2007 May;39(10):613-22. Epub 2007 Mar 26. PubMed PMID: 17384658.<\/p>\n

Sissung TM ve ark. ABCB1 genotipleri ile paklitaksel arac\u0131l\u0131 periferik n\u00f6ropati ve n\u00f6tropeni aras\u0131ndaki ili\u015fki. Eur J Cancer. 2006 Nov;42(17):2893-6. Epub 2006 Sep 6. PubMed PMID: 16950614; PubMed Central PMCID: PMC1647318.<\/p>\n

Engelhardt M, Ihorst G, Behringer D, Finke J, Roth B. Multipl miyelomlu hastalar\u0131n karde\u015flerinde monoklonal B-h\u00fccre hastal\u0131\u011f\u0131 insidans\u0131. Haematologica. 2006 Feb;91(2):274-6. PubMed PMID: 16461322.<\/p>\n

Mielke S, Sparreboom A, Behringer D, Mross K. Haftal\u0131k rejimle tedavi edilen ileri kanserli hastalarda paklitaksel farmakokineti\u011fi ve kemoterapiye yan\u0131t. Anticancer Res. 2005 Nov-Dec;25(6C):4423-7. PubMed PMID: 16334120.<\/p>\n

Chan S, ve ark. Lokal ileri veya metastatik meme kanserinde yo\u011fun \u00f6n tedavi alm\u0131\u015f hastalarda mTOR\u2019un yeni bir inhibit\u00f6r\u00fc olan temsirolimus (CCI-779) ile faz II \u00e7al\u0131\u015fma. J Clin Oncol. 2005 Aug 10;23(23):5314-22. Epub 2005 Jun 13. PubMed PMID: 15955899.<\/p>\n

Karthaus M, ve ark. \u0130leri kolorektal kanserli hastalarda irinotekan (CPT-11) kaynakl\u0131 diyarenin \u00f6nlenmesi i\u00e7in oral yoldan uygulanan budesonid ile prospektif, \u00e7ift k\u00f6r, plasebo kontroll\u00fc, \u00e7ok merkezli, randomize faz III \u00e7al\u0131\u015fma. Oncology 68(4-6):326-332, 2005<\/p>\n

Mielke S, ve ark. \u0130leri kanserli hastalarda paklitaxwl farmakokineti\u011fi ile periferik n\u00f6ropati geli\u015fimi aras\u0131ndaki ili\u015fki. Clin. Cancer Res. 11(13):4843-50, 2005<\/p>\n

Mross K, ve ark. \u0130leri solid t\u00fcm\u00f6rl\u00fc hastalarda g\u00fcnl\u00fck inf\u00fczyon \u015feklinde uygulanan kamptotesin glikokonjugat\u0131 BAY 38-3441\u2019in faz I klinik ve farmakokinetik sstudy\u2019si. Ann. Oncol. 15(8):1284-94, 2004<\/p>\n

Spyridonidis A, ve ark. Azalt\u0131lm\u0131\u015f yo\u011funluklu haz\u0131rlama rejimi, standart haz\u0131rlama ile kar\u015f\u0131la\u015ft\u0131r\u0131ld\u0131\u011f\u0131nda, in vitro kemik ili\u011fi stromas\u0131n\u0131n b\u00fcy\u00fcme kapasitesini korur; stroma konak k\u00f6kenli kalmaya devam eder. Stem Cells Dev. 14(2):213-22, 2005<\/p>\n

Zeiser R, Burger JA, Bley TA, Windfuhr-Blum M, Schulte-Monting J, Behringer DM. Klinik takip, neoplastik menenjit tan\u0131s\u0131nda manyetik rezonans g\u00f6r\u00fcnt\u00fcleme ile beyin-omurilik s\u0131v\u0131s\u0131n\u0131n imm\u00fcnositolojisinin farkl\u0131 do\u011fruluk d\u00fczeylerine i\u015faret etmektedir \u2013 tek merkez deneyimi. Br J Haematol. 124(6):762-8, 2004<\/p>\n

Spyridonidis A, Schmitt-Graff A, Tomann T, Dwenger A, Follo M, Behringer D, Finke J. \u0130nsan hematopoietik h\u00fccre nakli sonras\u0131 epitel doku kimerizmi ger\u00e7ek bir olgudur. Am J Pathol. 164(4):1147-55, 2004<\/p>\n

Roesler KW ve ark. Primer biliyer sirozda antikorlar\u0131n hedefi olarak, t\u00fcrden ba\u011f\u0131ms\u0131z bir bakteriyel protein olan bakteriyel RNA polimeraz\u0131n beta alt biriminin tan\u0131mlanmas\u0131. Dig Dis Sci. 48(3):561-9, 2003<\/p>\n

Burger JA, Spoo A, Dwenger A, Burger M, Behringer D. CXCR4 kemokin resept\u00f6rleri (CD184) ve alfa4beta1 integrinleri, insan CD34+ progenit\u00f6rlerinin ve akut miyeloid l\u00f6semi h\u00fccrelerinin kemik ili\u011fi stromal h\u00fccrelerinin alt\u0131na spontan g\u00f6\u00e7\u00fcn\u00fc (ps\u00f6doemperipolez) arac\u0131l\u0131k eder. Br J Haematol. 122(4):579-89, 200<\/p>\n

Mielke S, Mross K, Gerds TA, Schmidt A, Wasch R, Berger DP, Lange W, Behringer D. Haftal\u0131k ara vermeden uygulanan paklitaksel inf\u00fczyonlar\u0131n\u0131n 1 saate kar\u015f\u0131 3 saatlik uygulamas\u0131nda kar\u015f\u0131la\u015ft\u0131rmal\u0131 n\u00f6rotoksisite. Anticancer Drugs14(10):785-92, 2003<\/p>\n

Lohr J, Mielke S, Lubbert M, Behringer D. Metastatik prostat kanseri olan ve edinilmi\u015f a\u011f\u0131r hipogammaglobulinemi ile olgun periferik kan B-h\u00fccrelerinin tamamen yoklu\u011fu bulunan bir hastada \u00f6l\u00fcmc\u00fcl sonu\u00e7. In Vivo17(5):505-7, 2003<\/p>\n

Behringer B ve ark. Akut miyeloid l\u00f6semili ya\u015fl\u0131 hastalarda ind\u00fcksiyon veya k\u00fcratif olmayan tedavi alanlarda prognoz: tek merkezli retrospektif \u00e7al\u0131\u015fma. Annals of Hematology 82(7):381-9, 2003<\/p>\n

K. Mross, B. ve ark. 1 saatlik ve 3 saatlik paklitaksel inf\u00fczyon farmakokineti\u011finin kar\u015f\u0131la\u015ft\u0131r\u0131lmas\u0131: randomize bir \u00e7al\u0131\u015fman\u0131n sonu\u00e7lar\u0131; Onkologie25:503-508, 2002<\/p>\n

S. Klippel, ve ark. Polisitemia Rubra Vera\u2019da a\u015f\u0131r\u0131 eksprese edilen yeni bir hematopoietik h\u00fccre y\u00fczey resept\u00f6r\u00fc PRV-1\u2019in biyokimyasal karakterizasyonu. Blood 100:2442-2448, 2002<\/p>\n

Spyridonidis A, Fischer KG, Glocker FX, Fetscher S, Klisch J, Behringer D. Hodgkin hastal\u0131\u011f\u0131 \u00f6ncesinde paraneoplastik serebellar dejenerasyon ve nefrotik sendrom: olgu sunumu ve literat\u00fcr derlemesi. European Journal of Haematology 68:318-321,2002<\/p>\n

H. Gelderblom, K. Mross, A. ten Tije, D. Behringer, S. Mielke, D. van Zomeren, J. Verweij, A. Sparreboom. 1 ve 3 saatlik inf\u00fczyonlar s\u0131ras\u0131nda serbest (ba\u011flanmam\u0131\u015f) paklitakselin kar\u015f\u0131la\u015ft\u0131rmal\u0131 farmakokineti\u011fi. J Clin Oncol 20:574-581, 2002<\/p>\n

M. Engelhardt, J. Douvillle, D. Behringer, A. J\u00e4hne, A. Smith, R. Mertelsmann, W. Lange: Miyeloablatif (STAMP V) kemoterapi sonras\u0131 ex vivo perf\u00fczyon k\u00fclt\u00fcr\u00fc ile geni\u015fletilmi\u015f kemik ili\u011fi (BM) h\u00fccrelerinin kullan\u0131m\u0131. Bone Marrow Transplantation, 27:249-259, 2001<\/p>\n

D. Behringer, A. Spyridonidis, S. Fetscher, A. Schmitt-Gr\u00e4ff, S. H\u00f6gerle & R. Kaiser: E\u015flik eden Borrelia Burgdorferi enfeksiyonu olan bir hastada Hodgkin hastal\u0131\u011f\u0131 ve k\u00fc\u00e7\u00fck h\u00fccreli d\u0131\u015f\u0131 akci\u011fer kanseri tan\u0131s\u0131ndan \u00f6nce geli\u015fen paraneoplastik polin\u00f6ropati, Annals of Hematology 80: 232-235, 2001<\/p>\n

Behringer D, Schaufler J, Kresin V, L\u00fcbbert M, Lindemann A: \u0130nsan miyeloid h\u00fccre hatlar\u0131nda farkl\u0131la\u015fma ile ili\u015fkili sitokin ve kemokin ekspresyon paterninin mod\u00fclasyonu. Leukemia Research 25:141-149, 2001<\/p>\n

Mathias Oelke, Toshiro Kurokawa, Iris Hentrich, Dirk Behringer, Vincenzo Cerundolo*, Albrecht Lindemann and Andreas Mackensen: Sitokin sekresyonuna dayal\u0131 zenginle\u015ftirme sonras\u0131 CD8+ antijen-spesifik sitotoksik T lenfositlerinin fonksiyonel karakterizasyonu: MHC-tetramer teknolojisi ile kar\u015f\u0131la\u015ft\u0131rma. Scand. J. Immunol. 52:544-549, 2000<\/p>\n

Veelken H, Wasch R, Behringer D, Bertz H, Finke J. Azalt\u0131lm\u0131\u015f haz\u0131rlama rejimi ile allojenik k\u00f6k h\u00fccre nakli sonras\u0131 saf eritrosit aplazisi. Bone Marrow Transplant. 26(8):911-5, 2000<\/p>\n

Finke J, Bertz, H, Schmoor C, Veelken H, Behringer D, W\u00e4sch R, Kunzmann R, Heidecker L, Lang H, Meyer-K\u00f6nig U, Mertelsmann R: Canl\u0131da anti-T-h\u00fccre globulini kullan\u0131larak akraba d\u0131\u015f\u0131 don\u00f6rlerden allojenik kemik ili\u011fi nakli. British Journal of Haematology 111:303-313, 2000<\/p>\n

\u00d6lke M, M\u00f6hrle U, Chen J, Behringer D, Lindemann A, Mackensen A: T\u00fcm\u00f6r imm\u00fcnoterapisinde adoptif transfer i\u00e7in CD8(+) Melan-A-spesifik sitotoksik T lenfositlerinin olu\u015fturulmas\u0131 ve safla\u015ft\u0131r\u0131lmas\u0131. Clin Cancer Res. 6(5):1997-2005, 2000<\/p>\n

W\u00fcrthner J, K\u00f6hler G, Behringer D, L\u00fcbbert M: Hiperl\u00f6kositozlu akut miyeloid l\u00f6semide kemoterapi ba\u015flang\u0131c\u0131n\u0131 komplike eden, kanama ile seyreden l\u00f6kostaz. Cancer 85:368-74, 1999<\/p>\n

Behringer D, H Bertz, C Schmoor*, C Berger, A Dwenger and J Finke. Uyumlu akraba don\u00f6rlerden allojenik hematopoietik nakil sonras\u0131 lenfosit yeniden yap\u0131lanmas\u0131: CD34+ se\u00e7ilmi\u015f PBPC greftlerinin se\u00e7ilmemi\u015f PBPC greftleri ve BM greftleri ile kar\u015f\u0131la\u015ft\u0131r\u0131lmas\u0131. Bone Marrow Transplantation, 24, 295-302, 1999<\/p>\n

Berger C, Bertz H, Schmoor C, Behringer D, Potthoff K, Mertelsmann R, Finke J: G\u00f6n\u00fcll\u00fc akraba d\u0131\u015f\u0131 don\u00f6rlerden allojenik kemik ili\u011fi nakli (BMT) sonras\u0131 hematopoietik toparlanma ve sonu\u00e7lar \u00fczerine rekombinant insan gran\u00fclosit koloni uyar\u0131c\u0131 fakt\u00f6r\u00fcn\u00fcn (filgastrim) etkisi. Bone Marrow Transplantation 23:983-990, 1999<\/p>\n

Spyridonidis A, Bernhardt W, Behringer D, Azemar M, Pflug A, Mertelsmann R, Henschler R: Meme karsinomu h\u00fccrelerinin proliferasyonu ve sa\u011fkal\u0131m\u0131, CD34+ kan progenit\u00f6r h\u00fccrelerinin ex vivo geni\u015fletilmesinde kullan\u0131lan k\u00fclt\u00fcr ko\u015fullar\u0131ndan etkilenmektedir. Blood 93:1-11, 1999<\/p>\n

Lahn M, Fisch, P, K\u00f6hler G., Veelken H, Hentrich I, Behringer D, Muschal B, Kulmburg P, Ikl\u00e9 D, Lindemann A: \u0130nsan renal h\u00fccreli karsinom t\u00fcm\u00f6r h\u00fccre k\u00fclt\u00fcrlerinde proinflamatuvar ve T h\u00fccresi inhibit\u00f6r sitokinler y\u00fcksek d\u00fczeylerde salg\u0131lan\u0131r. European Urology, 35:70-80, 1999<\/p>\n

Spyridonidis A, Bernhardt W, Fetscher S, Behringer D, Mertelsmann R, Henschler R: Meme kanseri hastalar\u0131ndan al\u0131nan otolog hematopoietik \u00fcr\u00fcnlerde minimal rezid\u00fcel hastal\u0131k. Annals of Oncology 9:821-826, 1998<\/p>\n

Fetscher S, L\u00fcbbert M, Kanz L, Behringer D, Finke J, Mertelsmann R, Lange W: BEAM kemoterapisi ve otolog nakil sonras\u0131 n\u00fcks eden Non-Hodgkin lenfoman\u0131n BU\/CY kemoterapisi ve kurtarma nakli ile tedavisi. Bone Marrow Transplantation 9:527-528, 1997<\/p>\n

Behringer D, Kresin V, Henschler R, Mertelsmann R, Lindemann A: CD34+ hematopoietik progenit\u00f6r h\u00fccreler taraf\u0131ndan sitokin ve kemokin \u00fcretimi \u2013 tek h\u00fccrelerde saptama. British Journal of Haematology 97: 9-14, 1997<\/p>\n

Weber-Nordt RM, Henschler R, Schott E, Wehinger J, Behringer D, Mertelsmann R, Finke J: \u0130nterl\u00f6kin-10, primer insan CD34+ progenit\u00f6r h\u00fccrelerinde bcl-2 ekspresyonunu art\u0131r\u0131r ve sa\u011fkal\u0131m\u0131 destekler. Blood 88:2549-2558, 1996<\/p>\n

Waller CF, Bertz H, Wenger MK, Fetscher S, Hardung M, Engelhardt M, Behringer DM, Lange W, Mertelsmann R, Finke J: Allojenik nakil i\u00e7in periferik kan progenit\u00f6r h\u00fccrelerinin mobilizasyonu \u2013 y\u00fcksek doz RhG-CSF rejiminin etkinli\u011fi ve toksisitesi. Bone Marrow Transplantation 18:279-283, 1996<\/p>\n

Vogel W, Behringer D, Scheding S, Kanz L, Brugger W: CD34+ periferik kan progenit\u00f6r h\u00fccrelerinin ex vivo geni\u015fletilmesi \u2013 kontamine epitel t\u00fcm\u00f6r h\u00fccrelerinin geni\u015flemesi a\u00e7\u0131s\u0131ndan sonu\u00e7lar. Blood 8:2707-2713, 1996<\/p>\n

Finke J, Brugger W, Bertz H, Behringer D, Kanz L, Mertelsmann R: Uyumlu akraba don\u00f6rlerden pozitif se\u00e7ilmi\u015f periferik kan CD34+ progenit\u00f6r h\u00fccreleri ile allojenik nakil. Bone Marrow Transplantation 18: 1081-1086, 1996<\/p>\n

Behringer D, Sunderer B, Andersson U, Kresin V, Mertelsmann R, Lindemann A: \u0130mm\u00fcnoenzimatik \u00e7ift boyama ile tek h\u00fccre d\u00fczeyinde sitokin ve imm\u00fcnfenotipin e\u015fzamanl\u0131 saptanmas\u0131. Histochemical Journal 28:461-466, 1996<\/p>\n

Behringer DM, Schaefer HE, Kunzmann R, Mertelsmann R, D\u00f6lken G. Miyeloproliferatif sendrom \u00f6zellikleri olan T-h\u00fccreli lenfomal\u0131 bir hastada t(8q13q) translokasyonu. Leukemia 9:988-992, 1995<\/p>\n

Behringer DM, Meyer K-H, Veh RW: N\u00f6roaktif amino asitler ve n\u00f6ropeptitlere kar\u015f\u0131 antikorlar. II. Tek bir t\u00fcrden i\u015faretli primer antikorlar ile n\u00f6roaktif maddelerin e\u015fzamanl\u0131 imm\u00fcnoenzimatik \u00e7ift boyamas\u0131 ve ABC y\u00f6ntemi ile hapten-antihapten-k\u00f6pr\u00fc (HAB) tekni\u011finin kombinasyonu. J Histochem Cytochem 39:761-770, 1991<\/p>\n

Meyer K-H, Behringer DM, Veh RW. N\u00f6roaktif amino asitler ve n\u00f6ropeptitlere kar\u015f\u0131 antikorlar. I. Amino asitlerin veya peptitlerin glutaraldehit temelli olarak ta\u015f\u0131y\u0131c\u0131 proteinlere ba\u011flanmas\u0131 i\u00e7in imm\u00fcnizasyonda kullan\u0131lacak geli\u015ftirilmi\u015f iki a\u015famal\u0131 bir prosed\u00fcr\u00fcn geli\u015ftirilmesi. J Histochem Cyto<\/p>\n<\/div><\/div><\/div><\/section>\n

Behringer D, Engelhardt R: Meme kanseri, s. 436-448. \u201cDas Rote Buch\u201d i\u00e7inde, Edt: Berger D, Engelhardt R, Mertelsmann R; 2. bask\u0131:, 2002<\/p>\n

Finke J, Bertz H, Veelken H, Behringer D, Kunzmann R, W\u00e4sch R, Mertelsmann R: Allojenik periferik kan k\u00f6k h\u00fccre nakli i\u00e7in fludarabin temelli d\u00fc\u015f\u00fck toksisiteli haz\u0131rlama. In: Proceedings of the 4th International Stem Cell Workshop: High-Dose Therapy and Transplantation of Haematopoietic Stem Cells. Ba\u015fkan ve edit\u00f6r: Wolfgang Schulze, Bad Saarow; Blackwell-Wissenschafts-Verlag Berlin, Wien, 2000, s. 9-14<\/p>\n

Behringer D, Lindemann A: \u0130mm\u00fcnositoloji, \u201cDas Rote Buch\u201d, Edt: Berger D, Engelhardt R, Mertelsmann R, 2. bask\u0131:, 2002<\/p>\n

Mertelsmann R, Engelhardt R, Behringer D, Berger D, Hen\u00df H (Edit\u00f6rler): Das Rote Buch gcp-m@nual. Ecomed Verlag, Landsberg, Lech, 2002, bask\u0131da<\/p>\n<\/div><\/div><\/div><\/section>\n

Veh RW, Behringer D, Andres K: Avidin-Biyotin temelli sialik asit histokimyas\u0131. Verh. Anat. Ges. 78:115-116, 1984 (Sunum)<\/p>\n

Behringer D, Veh R: Yeni bir HAB tekni\u011fi \u2013 haptenlenmi\u015f primer antikorlar\u0131n imm\u00fcnoenzimatik boyanmas\u0131nda trinitrofenille\u015ftirilmi\u015f alkalen fosfataz. Anat. Anz. 161:122, 1986 (Poster bildirisi)<\/p>\n

Veh R, Habbes H, Meyer K, Behringer D: N\u00f6roaktif amino asitlerin imm\u00fcnositokimyas\u0131 \u2013 imm\u00fcnolojik olarak karakterize edilmi\u015f antikorlar\u0131n morfolojik kalibrasyonu ile \u00f6zg\u00fcll\u00fcklerin de\u011ferlendirilmesi. Biol. Chem. H-S 369:1214, 1988 (Poster bildirisi)<\/p>\n

Veh RW, Meyer KH, Behringer DM, Sch\u00e4tz CR, Petrasch E, Andres KH: N\u00f6roaktif amino asitler ve n\u00f6ropeptitlere kar\u015f\u0131 antikorlar. S\u0131\u00e7an\u0131n talamus, hipokampus, serebellum ve serebral korteksinde GABA ve glutamat benzeri imm\u00fcnreaktivitelerin g\u00f6sterimi i\u00e7in asetilkolinesteraz sitokimyas\u0131 ile imm\u00fcnositokimyasal \u00e7ift boyama tekniklerinin kombinasyonu. Acta histochemica, Suppl. Band 37, 189, 1989 (Poster bildirisi)<\/p>\n

Behringer D, Aaron D, Veltri E: Otomatik implante edilebilir kardiyoverter-defibrilat\u00f6r\u00fc reddeden refrakter ventrik\u00fcler ta\u015fiaritmi hastalar\u0131n\u0131n sonu\u00e7lar\u0131. J. Americ. Coll. Cardiol. 17 (Suppl. 2): 351A, 1991 (Sunum)<\/p>\n

Mackensen A, Veelken H, Behringer D, Lahn M, Rosenthal F, Kulmburg P, Wagner E, Mertelsmann R, Lindemann A: \u0130nsan renal h\u00fccreli karsinom h\u00fccrelerine resept\u00f6r arac\u0131l\u0131 \u0130nterl\u00f6kin-2 (IL-2) gen transferi. Onkologie 17 (Suppl.), 94, 1994 (Sunum #373)<\/p>\n

Behringer D, Kresin V, Veelken H, Mackensen A, Sunderer B, Mertelsmann R, Lindemann A: Tek h\u00fccre d\u00fczeyinde insan h\u00fccrelerinin sitokin \u00fcretimi ve imm\u00fcnfenotipinin e\u015fzamanl\u0131 karakterizasyonu. Onkologie 17 (Suppl.), 8, 1994 (Poster bildirisi #29)<\/p>\n

Lahn M, K\u00f6hler G, Behringer D, Kulmburg P, Veelken H, Rosenthal F, Mackensen A, Mertelsmann R, Lindemann A: \u0130nsan renal h\u00fccreli karsinomlar\u0131n\u0131n primer k\u00fclt\u00fcrlerinde sitokin sekresyonu. Onkologie 17 (Suppl.), 86, 1994 (Poster bildirisi #344)<\/p>\n

Winkler J, Behringer D, Mertelsmann R, Brugger W, Kanz L: Pozitif se\u00e7ilmi\u015f CD34+ otolog periferik kan progenit\u00f6r h\u00fccreleri ile desteklenen y\u00fcksek doz kemoterapi sonras\u0131 hastalarda imm\u00fcn yeniden yap\u0131lanma. Bone Marrow Transplantation 15 (Suppl. 2), S40, 1995, (Poster bildirisi #184)<\/p>\n

Waller C, Bertz H, Engelhardt M, Hardung M, Fetscher S, Behringer D, Lange W, Mertelsmann R, Finke J: Allojenik periferik kan progenit\u00f6r h\u00fccre nakli (allo-PBPCT) i\u00e7in periferik kan progenit\u00f6r h\u00fccrelerinin (PBPC) mobilizasyonu: y\u00fcksek doz rhG-CSF rejiminin etkinli\u011fi ve toksisitesi. Bone Marrow Transplantation 17 (Suppl. 2), S71, 1995 (Poster bildirisi #24)<\/p>\n

Weber-Nordt R, Behringer D, Schott E, Henschler R, Mertelsmann R, Finke J: IL-10, bcl-2 yoksunlu\u011funun ind\u00fckledi\u011fi h\u00fccre \u00f6l\u00fcm\u00fcnden kemik ili\u011fi ve kandan t\u00fcretilmi\u015f insan CD34+ h\u00fccrelerini kurtar\u0131r. Blood 86 (Suppl. 1), 149a, 1995 (Poster bildirisi #585)<\/p>\n

Finke J, Brugger W, Bertz H, Einsele H, Behringer D, Kanz L, Mertelsmann R: Uyumlu akraba don\u00f6rlerden periferik kandan t\u00fcretilmi\u015f CD34+ se\u00e7ilmi\u015f progenit\u00f6r h\u00fccrelerin allojenik nakli. Klinik faz I\/II \u00e7al\u0131\u015fmas\u0131n\u0131n sonu\u00e7lar\u0131. Blood 86 (Suppl 1), 1995 (Sunum #1148)<\/p>\n

Spyridonidis A, Garbe A, Behringer D, Mertelsmann R, Henschler R: Transforming growth factor beta 1, CD34+ h\u00fccrelerin ex vivo k\u00fclt\u00fcr\u00fc s\u0131ras\u0131nda meme karsinomu h\u00fccrelerinin b\u00fcy\u00fcmesini inhibe eder. Blood 88 (Suppl. 1), 250a, (Sunum #433-II)<\/p>\n

Behringer D, Bertz H, Hardung-Backes M, Winkler J, Engelhardt M, Mertelsmann R, Finke J: CD34+ k\u00f6k h\u00fccre se\u00e7imi ile veya olmaks\u0131z\u0131n allojenik periferik kan progenit\u00f6r h\u00fccre nakli: takip ve imm\u00fcn yeniden yap\u0131lanma. Bone Marrow Transplantation 17 (Suppl. 1), S63, 1996 (Sunum #298)<\/p>\n

Behringer D, Kresin V, Henschler R, Mertelsmann R, Lindemann A: CD34+ hematopoietik progenit\u00f6r h\u00fccreler taraf\u0131ndan sitokin \u00fcretimi \u2013 tek h\u00fccre d\u00fczeyinde saptama. Annals of Hematology 73 (Suppl. 1-2), A68, 1996 (Poster bildirisi #269)<\/p>\n

Bertz H, Burger J, Behringer D, Mertelsmann R, Finke J: Allojenik BMT sonras\u0131 n\u00fcks eden multipl miyelomun allojenik buffy coat\u2019larla imm\u00fcnoterapi ile tedavisi. Bone Marrow Transplantation 17 (Suppl. 1), S69, 1996 (Poster bildirisi #320)<\/p>\n

Finke J, Behringer D, Bertz H, Winkler J, Potthoff K, Hardung M, Berger C, Mertelsmann R: CD34+ se\u00e7imi ile veya olmaks\u0131z\u0131n allojenik periferik kan k\u00f6k h\u00fccre nakli: h\u0131zl\u0131 imm\u00fcn yeniden yap\u0131lanma ve d\u00fc\u015f\u00fck GVHD insidans\u0131. Annals of Hematology 73 (Suppl. 1-2), A165, 1996, (Bildiri #658)<\/p>\n

Finke J, Bertz H, Behringer D, Bertz H, Berger C, Potthoff K, Winkler J, Hardung M, Mertelsmann R: CD34+ se\u00e7imi ile veya olmaks\u0131z\u0131n allojenik periferik kan k\u00f6k h\u00fccre nakli sonras\u0131 imm\u00fcn yeniden yap\u0131lanma ve GvHD\u2019nin kar\u015f\u0131la\u015ft\u0131r\u0131lmas\u0131. Blood 88 (Suppl. 1), 616a (Sunum #515-IV)<\/p>\n

Spyridonidis A, Garbe A, Behringer D, Mertelsmann R, Henschler R: CD34+ h\u00fccrelerin ex vivo k\u00fclt\u00fcr\u00fc s\u0131ras\u0131nda meme karsinomu h\u00fccrelerinin b\u00fcy\u00fcmesini inhibe etmek i\u00e7in transforming growth factor (TGF)-beta kullan\u0131m\u0131. Annals of Hematology 73 (Suppl. 1-2), A68, 1996 (Poster bildirisi #269)<\/p>\n

Spyridonidis A, Garbe A, Behringer D, Mertelsmann R, Henschler R: Transforming Growth Factor (TGF)-beta 1, CD34+ h\u00fccrelerin ex Vivo k\u00fclt\u00fcr\u00fc s\u0131ras\u0131nda meme karsinomu h\u00fccrelerinin b\u00fcy\u00fcmesini inhibe eder. Blood 88 (Suppl. 1), 250a, 1996 (Sunum #433-II)<\/p>\n

Finke J, Bertz H, Behringer D, Heidecker E, Kunzmann R, Lang H, Potthoff K, Mertelsmann R: Canl\u0131da tav\u015fan anti-T lenfosit globulini, uyumlu veya uyumsuz akraba d\u0131\u015f\u0131 don\u00f6rlerden allojenik BMT sonras\u0131 a\u011f\u0131r GvHD\u2019yi etkin bi\u00e7imde \u00f6nler. Bone Marrow Transplantation 19 (Suppl. 1), S186, 1997 (Poster bildirisi P742)<\/p>\n

Behringer D, Schaufler J, Kresin V, Lindemann A: \u0130nsan miyeloid h\u00fccre hatlar\u0131nda sitokin ve kemokin paterni, farkl\u0131la\u015fman\u0131n ind\u00fcklenmesi ile mod\u00fcle edilir. Onkologie 20 (suppl. 1), 64, 1997 (Poster bildirisi #234)<\/p>\n

Bertz H, Afting M, Behringer D, Kunzmann R, Lang H, Potthoff K, W\u00e4sch R, Mertelsmann R, Finke J: Nakil \u00f6ncesi canl\u0131da tav\u015fan ATG ile T-h\u00fccre deplesyonu, uyumsuz ve uyumlu akraba d\u0131\u015f\u0131 allojenik kemik ili\u011fi naklinde a\u011f\u0131r greft-versus-host hastal\u0131\u011f\u0131 insidans\u0131n\u0131 azalt\u0131r. Onkologie 20 (suppl. 1), 15, 1997 (Sunum #47) <\/p>\n

Thomas A, Willebrand J, Lindemann A, Behringer D: Uzam\u0131\u015f trombositopenisi olan hastalarda retik\u00fcle trombositlerin de\u011ferlendirilmesi: Onkologie 20 (suppl. 1), 290, 1997 (Poster bildirisi #290)<\/p>\n

Spyridonidis A, Bernhardt W, Behringer D, Pflug A, Mertelsmann R, Henschler R: CD34+ kan progenit\u00f6r h\u00fccrelerinin ex vivo geni\u015fletilmesinde kullan\u0131lan k\u00fclt\u00fcr ko\u015fullar\u0131, meme karsinomu h\u00fccrelerinin proliferasyonu ve sa\u011fkal\u0131m\u0131n\u0131 etkiler. Blood 90 (Suppl. 1), 422a, 1997 (Kongre bildirisi #1873)<\/p>\n

Spyridonidis A Bernhardt W, Behringer D, Pflug A, Mertelsmann R, Henschler R: CD34+ kan progenit\u00f6r h\u00fccrelerinin (BPC) ex vivo geni\u015fletilmesinde kullan\u0131lan k\u00fclt\u00fcr ko\u015fullar\u0131, meme karsinomu h\u00fccrelerinin sa\u011fkal\u0131m\u0131n\u0131 ve proliferasyonunu etkiler. Onkologie 20 (suppl. 1), 90, 1997 (Poster bildirisi #336)<\/p>\n

Spyridonidis A, Bernhardt W, Behringer D, Mertelsmann R, Henschler R: Bir k\u00fclt\u00fcr basama\u011f\u0131, meme kanseri hastalar\u0131n\u0131n kemik ili\u011finde gizli t\u00fcm\u00f6r h\u00fccrelerinin saptanmas\u0131n\u0131 belirgin \u00f6l\u00e7\u00fcde art\u0131r\u0131r. Blood 90 (Suppl. 1), 215a, 1997 (Sunum #409-II)<\/p>\n

Berger C, Bertz H, Behringer D, W\u00e4sch R, Afting M, Potthoff K, Mertelsmann R, Finke J: Allojenik kemik ili\u011fi ve periferik kan k\u00f6k h\u00fccre nakli sonras\u0131 hematopoietik toparlanma. Onkologie 20 (suppl. 1), 144, 1997 (Poster bildirisi #553)<\/p>\n

Finke J, Bertz H, Kunzmann R, Behringer D, Afting M, Heidecker E, Lang H, Potthoff K, W\u00e4sch R, Mertelsmann R: Akraba d\u0131\u015f\u0131 don\u00f6rlerden allojenik nakil: canl\u0131da T h\u00fccresi deplesyonu kullan\u0131m\u0131 ile iyile\u015ftirilmi\u015f sonu\u00e7lar. Blood 90 (Suppl. 1), 103a, 1997 (Kongre bildirisi #451-I)<\/p>\n

Behringer D, Engelhardt M, Schmoor C, Bertz H, Lohr J, Finke J: Hematolojik ve klinik sonu\u00e7lar a\u00e7\u0131s\u0131ndan allojenik periferik kan (PB) ve kemik ili\u011fi (BM) greftlerinde CD34+ belirlemenin rol\u00fc. Annals of Haematology 77 (suppl II), S79, 1998 (Poster bildirisi #312)<\/p>\n

Behringer D, Bertz H, Finke J: CD34+ se\u00e7ilmi\u015f periferik kan progenit\u00f6r h\u00fccre (PBPC) greftleri veya se\u00e7ilmemi\u015f PBPC greftleri ile uyumlu akraba don\u00f6rlerden nakil sonras\u0131 benzer lenfosit yeniden yap\u0131lanmas\u0131. Annals of Haematology 77 (suppl II), S79, 1998 (Poster bildirisi #311)<\/p>\n

Finke J, Bertz H, Afting M, Behringer D, Berger C, Heidecker L, Kunzmann R, Marks R, Potthoff K W\u00e4schr R, Winkler J, Mertelsmann R: CD34+ se\u00e7ilmi\u015f veya se\u00e7ilmemi\u015f periferik kan progenit\u00f6r h\u00fccrelerinin allojenik nakli. Bone Marrow Transplantation 22 (Suppl. 2), S8, 1998 (Kongre bildirisi #SP13)<\/p>\n

Engelhardt M, Henschler R, Kalle C, Behringer D, Stockschl\u00e4der M, Finke J, Schulz G, Mertelsmann R, Lange W: Ex vivo perf\u00fczyon k\u00fclt\u00fcr\u00fc ile geni\u015fletilmi\u015f kemik ili\u011fi h\u00fccrelerinin nakli, miyeloablatif kemtoherapi sonras\u0131 kal\u0131c\u0131 hematopoietik yeniden yap\u0131lanma sa\u011flar. Annals of Haematology 77 (suppl II), S29, 1998 (Sunum #111)<\/p>\n

Engelhardt M, Douville J, de Reys S, von Kalle C, Behringer D, Schulz G, Armstrong D, Mertelsmann R, Lange W: Ex Vivo perf\u00fczyon k\u00fclt\u00fcr\u00fc ile geni\u015fletilmi\u015f kemik ili\u011fi h\u00fccrelerinin nakli, miyeloablatif kemoterapi sonras\u0131 kal\u0131c\u0131 hematopoietik yeniden yap\u0131lanma sa\u011flar. Blood 92 (Suppl. 1), 126a, 1998 (Poster bildirisi #509)<\/p>\n

W\u00fcrthner J, Behringer D, K\u00f6hler G, Daskalakis M, Mertelsmann R, Lindemann A, L\u00fcbbert M: L\u00f6kostaz\u0131 takiben \u00f6l\u00fcmc\u00fcl serebral kanama \u2013 Akut<\/p>\n

Hiperl\u00f6kositozlu miyelomonositik l\u00f6semi. Blood 92 (Suppl. 1), 214b, 1998 (Kongre bildirisi #3920)<\/p>\n

Spyridonidis A, Bernhardt W, Azemar M, Behringer D, Pflug A, Wels W, Groner B, Henschler R: CD34+ geni\u015fletme k\u00fclt\u00fcr\u00fc s\u0131ras\u0131nda meme karsinomu h\u00fccrelerinin ar\u0131nd\u0131r\u0131lmas\u0131 (purging). Annals of Haematology 77 (suppl II), S210, 1998 (Poster bildirisi #834)<\/p>\n

Engelhardt M, Douville J, von Kalle C, Behringer D, Armstrong D, Mertelsmann R, Lange W: Miyeloablatif kemoterapi sonras\u0131 ex vivo perf\u00fczyon k\u00fclt\u00fcr\u00fc ile geni\u015fletilmi\u015f kemik ili\u011fi (BM) h\u00fccrelerinin kullan\u0131m\u0131na ili\u015fkin g\u00fcncelleme. Onkologie 22 (suppl 1), 27, 1999 (Poster bildirisi #74)<\/p>\n

Behringer D, Bauer D, Henschler R, Lindemann A: M-CSF, CD34+ hematopoietik progenit\u00f6r h\u00fccreler (CD34+HPC) taraf\u0131ndan ex Vivo geni\u015fleme s\u0131ras\u0131nda ve kemik ili\u011fi stromas\u0131 \u00fczerinde k\u00fclt\u00fcr s\u0131ras\u0131nda salg\u0131lan\u0131r. Onkologie 22 (suppl 1), 178, 1999 (Sunum #680)<\/p>\n

Finke J, Bertz H, Veelken H, W\u00e4sch R, Behringer D, Illerhaus G, v. Kalle C, Kunzmann R, Lang H, Schwabe M, Mertelsmann R: ATG ile canl\u0131da T h\u00fccresi deplesyonu, akraba d\u0131\u015f\u0131 don\u00f6r k\u00f6k h\u00fccre naklinde GvHD\u2019yi azalt\u0131r. Blood 94 (Suppl. 1), 713A, (\u00d6zet 3148, kongre sunumu), 1999<\/p>\n

Finke, J., H. Bertz, ve ark., …. D. Behringer. \u201cAllojenik PBSCT i\u00e7in fludarabin temelli d\u00fc\u015f\u00fck toksisiteli haz\u0131rlama.\u201d Bone Marrow Transplantation 23: S3c (1999) <\/p>\n

W\u00e4sch R, Sauer B, Behringer D, Engelhardt M, Bertz H, Finke J: Allojenik k\u00f6k h\u00fccre nakli sonras\u0131 kemik ili\u011fi stromal h\u00fccrelerinin don\u00f6r k\u00f6keni. Blood 94 (10, Suppl. 1), #166 (Poster bildirisi ASH), 1999<\/p>\n

Mielke S, Behringer D, Henss H, Lindemann A: PELV rejimi ile tedavi edilen ileri mide kanserli on bir hastada yan\u0131t ve sa\u011fkal\u0131m. J Cancer Res Clin Oncol 126 (Suppl) R111; Abstract S0235 P-33, 2000<\/p>\n

Behringer D, Mielke S, Bertz H, Dwenger A, Burger J, Finke J: Akraba d\u0131\u015f\u0131 don\u00f6rlerden BMT sonras\u0131 ve anti-timosit globulin ile canl\u0131da T-h\u00fccre deplesyonu sonras\u0131nda lenfosit yeniden yap\u0131lanmas\u0131. Onkologie 23 (Sonderheft 7) 122; #460, 2000<\/p>\n

B. Behringer, R. Kunzmann, C. Schmoor, D. Behringer, R. Mertelsmann, M. L\u00fcbbert: Serum laktat dehidrogenaz (LDH), >55 ya\u015f akut miyeloid l\u00f6semi (AML) hastalar\u0131nda genel sa\u011fkal\u0131m i\u00e7in ba\u011f\u0131ms\u0131z bir prognostik fakt\u00f6r olarak. Blood 96 (11 Part 1): 123a, \u00d6zet #531 (Poster bildirisi ASH), 2000<\/p>\n

Jan A. Burger, Bingrong Zhou, Anne Dwenger, Dirk Behringer: CD34+ progenit\u00f6r h\u00fccrelerin kemik ili\u011fi stromal h\u00fccrelerinin alt\u0131na spontan g\u00f6\u00e7\u00fc (ps\u00f6doemperipolez), VLA-4 integrinleri ve CXCR4 kemokin resept\u00f6r\u00fcn\u00fc gerektirir ve CD34+ progenit\u00f6r h\u00fccrelerde veya CD34+ miyeloid l\u00f6semi h\u00fccrelerinde h\u00fccre d\u00f6ng\u00fcs\u00fc ilerlemesini farkl\u0131 \u015fekilde etkiler. Blood 96 (11 Part 1): 688a, \u00d6zet #2961 (Poster bildirisi ASH), 2000<\/p>\n

D. Behringer, S. Mielke, H. Bertz, J. Finke: Akraba d\u0131\u015f\u0131 donro kemik ili\u011fi nakli sonras\u0131 T-lenfosit yeniden yap\u0131lanmas\u0131 \u00fczerine ATG dozunun etkileri. Blood 96 (11 Part 2): 359b, \u00d6zet #5307 (ASH), 2000<\/p>\n

Oelke, M., A. Tuczek, …, D. Behringer, W. Kreisel. \u201cPBC hastalar\u0131nda kalretik\u00fclin ve bakteriyel RNA polimeraz\u0131na kar\u015f\u0131 periferik T-lenfositlerin spesifik Th-2 tipi reaksiyonu.\u201d Gastroenterology 120(5): 1825. (Poster bildirisi, AGA Atlanta, 2001)<\/p>\n

Burger, J. A., A. Burkle, D. Behringer. \u201cB h\u00fccreli kronik lenfositik l\u00f6semi h\u00fccreleri, kemokin B h\u00fccresi aktive edici kemokin-1 (BCA-1\/CXCL13) i\u00e7in fonksiyonel CXCR5 kemokin resept\u00f6rlerini eksprese eder.\u201d Blood 98(11): 639, (Poster bildirisi, ASH, 2001).<\/p>\n

Spyridonidis, A., T. Tomann, …, D. Behringer, J. Finke. \u201c\u0130nsan hematopoietik k\u00f6k h\u00fccre
\nnakli (HSCT) sonras\u0131 ba\u011f\u0131rsak epitelinin kimerik durumu.\u201d Blood 98(11): 3288, (Sunum, ASH, 2001) <\/p>\n

Bertz, H., D. Behringer, K. Potthoff, J. Finke: \u201cYa\u015fam\u0131n yedinci dekat\u0131nda aktif hastal\u0131\u011f\u0131 olan hastalarda akraba d\u0131\u015f\u0131 ve akraba don\u00f6rlerden allonakil.\u201d Bone Marrow Transplantation 27: S84-S84, (Poster bildirisi, EBMT, 2001)<\/p>\n

K. Mross, B. Niemann, C.Unger, D., N. Holl\u00e4nder, M. Schumacher, S. Mielke, D. Behringer. 1 saatlik ve 3 saatlik paklitaksel inf\u00fczyonunun farmakokineti\u011finin kar\u015f\u0131la\u015ft\u0131r\u0131lmas\u0131 \u2013 randomize bir \u00e7al\u0131\u015fman\u0131n sonu\u00e7lar\u0131. Journal of Clinical Oncology 20 (Part 1): 107a (#424; ASCO 2001) Poster bildirisi)<\/p>\n

Stephan Mielke, Klaus Mross Franz-Xaver Glocker, Clemens Unger, Dirk Behringer: Haftal\u0131k olarak bir saate kar\u015f\u0131 \u00fc\u00e7 saatlik paklitaksel inf\u00fczyonunda n\u00f6rotoksisite: faz III \u00e7al\u0131\u015fman\u0131n \u00f6n sonu\u00e7lar\u0131. Journal of Clinical Oncology 20 (Part 1): 107a (#425; ASCO 2001 Poster bildirisi)<\/p>\n

C. Dittrich, J. Beck, D. Behringer, C. Bokemeyer, M. Borner, M. De Santis, H. Fiebig, G. Gastl, R. Hofheinz, D. Hossfeld, H. Illiger, R. Morant, K. Mross, W. Quei\u00dfer, D. Reichert, M. Scheulen, J. Sch\u00fcller, J. von Pawel: Central European Society for Anticancer Drug Research-EWIV: Faz I ve II \u00e7al\u0131\u015fmalar. Onkologie 26 (Sonderheft 6):9, 2001<\/p>\n

Spyridonidis A, Dwenger A, Tomann T, Follo M, Behringer D, Finke J: \u0130nsan kemik ili\u011fi nakli sonras\u0131 ba\u011f\u0131rsak epitelinin kimerik durumu. Onkologie 24 (Sonderheft 6):12 (\u00d6zet #44); 2002<\/p>\n

Burger J, Birkle A, Behringer D. B h\u00fccreli kronik lenfositik l\u00f6semi h\u00fccreleri, kemokin B h\u00fccresi aktive edici kemokin-1 (BCA-1) i\u00e7in fonksiyonel CXCR5 kemokin resept\u00f6rlerini eksprese eder. Onkologie 24 (Sonderheft 6):76 (\u00d6zet #291); 2002<\/p>\n

Bertz H, Potthoff K, Behringer D, Finke J: Aktif miyeloid maligniteleri olan >60 ya\u015f hastalarda akraba d\u0131\u015f\u0131 ve akraba don\u00f6rlerden ba\u015far\u0131l\u0131 allonakil. Onkologie 24 (Sonderheft 6):121 (\u00d6zet #459); 2002 <\/p>\n

Engelhardt M, Wider D, Samek E, Bertz H, Behringer D, L\u00fcbbert M: Otolog ve allojenik nakil i\u00e7in imm\u00fcnomanyetik (Clinimacs) se\u00e7im cihaz\u0131 kullan\u0131larak periferik kan CD34+ h\u00fccrelerinin se\u00e7imi. Onkologie 24 (Sonderheft 6):161 (\u00d6zet #621); 2002<\/p>\n

Behringer B, Kunzmann R, Schmoor C, Behringer D, L\u00fcbbert M: >55 ya\u015f 139 akut miyeloid l\u00f6semi (AML) hastas\u0131nda sonu\u00e7lar\u0131n ve prognostik fakt\u00f6rlerin tek merkezli retrospektif analizi. Onkologie 24 (Sonderheft 6):194 (\u00d6zet #747); 2002<\/p>\n

Bernhardt W, Herling M, Behrens M, J\u00fcttner E, Hen\u00df H, Behringer D: Merkezi bir kontrol sistemi kullan\u0131larak kemoterapinin kalite g\u00fcvencesi. Onkologie 24 (Sonderheft 6):222 (\u00d6zet #858); 2002<\/p>\n<\/div><\/div><\/div><\/section>\n

Spyridonidis A, Behringer D, Henschler R: Meme kanserinde kemik ili\u011fi nakli: ar\u0131nd\u0131rma (purging) yapmal\u0131 m\u0131y\u0131z? Solid organ nakli alan\u0131ndan \u00e7\u0131kar\u0131lan dersler. Bone Marrow Transplantation\u2019a g\u00f6nderildi, devam edilmedi<\/p>\n

A. Thomas, J. Willebrand, D. Mattern*, G. K\u00f6hler*, J. Finke, A. Lindemann & D. Behringer: \u0130diyopatik trombositopenik purpural\u0131 veya allojenik hematopoietik k\u00f6k h\u00fccre nakli sonras\u0131 trombositopenisi olan hastalarda retik\u00fcle trombosit say\u0131lar\u0131n\u0131n tan\u0131sal etkisi; Europ. J. Haematology, 04\/01 reddedildi, devam edilmedi<\/p>\n

\u00d6lke M, Tuczek A, Behringer D, M\u00e4nnle H, Jensen D, R\u00f6ssler K-W, Kreisel W: Primer biliyer sirozda periferik T lenfositlerin kalretik\u00fclin ve bakteriyel RNA polimeraz\u0131na kar\u015f\u0131 Th-2 reaksiyonu. Alman Sindirim ve Metabolizma Hastal\u0131klar\u0131 Derne\u011fi\u2019nin 56. toplant\u0131s\u0131na sunuldu, 2001<\/p>\n

R\u00f6ssler K-W , W. Schmieder, G. Kurz, M. Kist, S. Batsford, E. Schiltz, M. \u00d6lke, A. Tuuczek, T. Dettenborn, D. Behringer, W. Kreisel. Primer biliyer sirozda (PBC) bakteriyel RNA polimeraz\u0131n \u00df alt birimine kar\u015f\u0131 antikorlar; Alman Sindirim ve Metabolizma Hastal\u0131klar\u0131 Derne\u011fi\u2019nin 56. toplant\u0131s\u0131na sunuldu, 2001<\/p>\n

K Mross, U Sauer, B H\u00e4ring, D Behringer, E. Brendel, C Unger: \u00dc\u00e7 haftada bir k\u0131sa inf\u00fczyon olarak uygulanan BAY 38-3441\u2019in doz art\u0131r\u0131ml\u0131 faz I farmakokinetik (PK) \u00e7al\u0131\u015fmas\u0131. 04\/01 ECCO\u2019ya sunuldu
\n\u0130leri solid t\u00fcm\u00f6rl\u00fc hastalarda BBR 3438\u2019in tolere edilebilirli\u011fi ve etkinli\u011fi \u00fczerine faz I doz art\u0131r\u0131ml\u0131 \u00e7al\u0131\u015fma D. <\/p>\n

Behringer1, R. Engelhardt1, R. Hofheinz2, A. Hochhaus2, R. Herrmann3, A. Stern4, G. Camboni5, A. Bernareggi5, ESMO 2002 taraf\u0131ndan kabul edildi<\/p>\n

J Lohr, S Mielke, M L\u00fcbbert, D Behringer: Metastatik prostat kanseri olan ve edinilmi\u015f a\u011f\u0131r hipogammaglobulinemi ile olgun periferik kan B-h\u00fccrelerinin tamamen yoklu\u011fu bulunan bir hastada \u00f6l\u00fcmc\u00fcl sonu\u00e7. Clin Lab Haematol\u2019a g\u00f6nderildi<\/p>\n

B. Roth, H. Bertz, J. Finke, D. Behringer. <\/high><\/p>\n<\/div><\/div><\/div><\/section>\n<\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":4,"featured_media":0,"parent":0,"menu_order":80,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-3923","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/thoraxzentrum-ruhrgebiet.de\/tr\/wp-json\/wp\/v2\/pages\/3923","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thoraxzentrum-ruhrgebiet.de\/tr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/thoraxzentrum-ruhrgebiet.de\/tr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/thoraxzentrum-ruhrgebiet.de\/tr\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/thoraxzentrum-ruhrgebiet.de\/tr\/wp-json\/wp\/v2\/comments?post=3923"}],"version-history":[{"count":3,"href":"https:\/\/thoraxzentrum-ruhrgebiet.de\/tr\/wp-json\/wp\/v2\/pages\/3923\/revisions"}],"predecessor-version":[{"id":3926,"href":"https:\/\/thoraxzentrum-ruhrgebiet.de\/tr\/wp-json\/wp\/v2\/pages\/3923\/revisions\/3926"}],"wp:attachment":[{"href":"https:\/\/thoraxzentrum-ruhrgebiet.de\/tr\/wp-json\/wp\/v2\/media?parent=3923"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}